Оценка эффективности применения различных аналогов инсулина в лечении сахарного диабета 2-го типа

Литература:
I.American Diabetes Association: standards of medical care in diabetes. Diabetes Care 2014; 37 (Suppl. 1): 5-13
2. Gerstein H., Yusuf S., Riddle M.C., et al. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008; 155 (1): 26-32
3. Riddle M., Umpierrez G., Digenio A., et al. Challenging the "Monnier concept": high basal (not postprandial) glucose dominates hyperglycemic exposure over a wide range of A1С on oral therapy, and contributes significantly even after addition of basal insulin [abstract]. Diabetes 2010; 59 (Suppl 1): 626
4. Manini R., Forlani G., Moscatiello S., et al. Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetes, nutr metab cardiovasc dis 2007; 17 (7): 493-8
5. Алгоритмы специализированной медицинской помощи больным сахарным диабетом / под ред. И. И. Дедова, М. В. Шестаковой. 6-й вып. М.,2013; 120 с.
6. Rosenstock J., Dailey G., Massi-Benedetti M., et al. Reduced hypoglycemia risk with insulin glargine: a metaanalysis comparing insulin glargine with human NPH in type 2 diabetes. Diabetes Care 2005; 28: 950-55
7. Chatterjee S., Jarvis-Kay J., Rengarajan T., et al. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes: the glargine and aspart study (GLASS): A randomized cross-over study. Diabetes Res Clin Pract 2007; 77: 215-222
8. Davies M., Storms F., Shutler S., et al. LANTUS study group Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005; 28: 1282-1288
9. Kennedy L., Herman W.H., Strange P., et al. GOALA1С Team Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006; 29: 1-8
10. Kacerovsky-Bielesz G, Dressier A, Freunscht R. Long-term glycemic control with insulin glargine in type 2 diabetes. Diabetes Res Clin Pract 2006; 71: 184-191.